KEAP1 and Alzheimer disease: In the present study, compared with AD + saline group, MSC-EVs treatment resulted in a decrease of Nrf2, HO-1, NQO1, iNOS (indicative of oxidative damage), and an increase of Keap1 expression in hippocampal tissue.